Beta-Nicotimamide-Adenine Dinucleotide Phosphate Reduced (NADPH)

<strong>beta-Nicotimamide-Adenine Dinucleotide Phosphate Reduced (NADPH)</strong>_x000D_ <strong>Catalog number:</strong> B2013895_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 833.4_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> beta-Nicotimamide-Adenine Dinucleotide Phosphate, Reduced (NADPH)_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Sharma R, Ramanathan A. The Aging Metabolome-Biomarkers to Hub Metabolites Proteomics. 2020 Mar;20(5-6):e1800407._x000D_ 2: Zeng H, Pan T, Zhan M, Hailiwu R, Liu B, Yang H, Li P. Suppression of PFKFB3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response Signal Transduct Target Ther. 2022 Sep 1;7(1):303._x000D_ 3: Ju HQ, Lin JF, Tian T, Xie D, Xu RH. NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications Signal Transduct Target Ther. 2020 Oct 7;5(1):231._x000D_ 4: Tran DH, Kesavan R, Rion H, Soflaee MH, Solmonson A, Bezwada D, Vu HS, Cai F, Phillips JA 3rd, DeBerardinis RJ, Hoxhaj G. Mitochondrial NADP(+) is essential for proline biosynthesis during cell growth Nat Metab. 2021 Apr;3(4):571-585._x000D_ 5: Koju N, Qin ZH, Sheng R. Reduced nicotinamide adenine dinucleotide phosphate in redox balance and diseases: a friend or foe? Acta Pharmacol Sin. 2022 Aug;43(8):1889-1904._x000D_ 6: Zhu J, Wang YF, Chai XM, Qian K, Zhang LW, Peng P, Chen PM, Cao JF, Qin ZH, Sheng R, Xie H. Exogenous NADPH ameliorates myocardial ischemia-reperfusion injury in rats through activating AMPK/mTOR pathway Acta Pharmacol Sin. 2020 Apr;41(4):535-545._x000D_ 7: Curtis WM, Seeds WA, Mattson MP, Bradshaw PC. NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson's Disease Cells. 2022 Aug 4;11(15):2416._x000D_ 8: Zhou Y, Wu J, Sheng R, Li M, Wang Y, Han R, Han F, Chen Z, Qin ZH. Reduced Nicotinamide Adenine Dinucleotide Phosphate Inhibits MPTP-Induced Neuroinflammation and Neurotoxicity Neuroscience. 2018 Nov 1;391:140-153._x000D_ 9: Gu Y, Sheng R, Wu J, Zhou Y, Qin ZH. Reduced nicotinamide adenine dinucleotide phosphate inhibits rat platelet aggregation and p38 phosphorylation Thromb Res. 2018 Nov;171:121-129._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/31578871">10: Sun H, Zhang F, Xu Y, Sun S, Wang H, Du Q, Gu C, Black SM, Han Y, Tang H. Salusin-_ Promotes Vascular Calcification via Nicotinamide Adenine Dinucleotide Phosphate/Reactive Oxygen Species-Mediated Klotho Downregulation Antioxid Redox Signal. 2019 Dec 20;31(18):1352-1370. </a>_x000D_ _x000D_ <strong>Products Related to beta-Nicotimamide-Adenine Dinucleotide Phosphate Reduced (NADPH) can be found at</strong> <a href="https://moleculardepot.com/product-category/Chemicals/"> Chemicals</a>